Showing results (81-90 of 376) with videos related to
Sort By:
Pageof 38
Peptides|January 5, 2002
Bioactivity of adrenomedullin and proadrenomedullin N-terminal 20 peptide in manM G Nicholls, J G Lainchbury, L K Lewis, et al.Hypertension (Dallas, Tex. : 1979)|November 1, 1994
Ouabain is not detectable in human plasmaL K Lewis, T G Yandle, J G Lewis, et al.The American Journal of Physiology|November 1, 1994
Effect of ouabain on pressor responsiveness in normal manG B Pidgeon, A M Richards, M G Nicholls, et al.Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 1, 1996
Natriuretic peptides in sheep with pressure overload left ventricular hypertrophyC J Charles, R J Kaaja, E A Espiner, et al.The American Journal of Physiology|June 1, 1997
Hemodynamic, hormonal, and renal effects of adrenomedullin in conscious sheepC J Charles, M T Rademaker, A M Richards, et al.The American Journal of Physiology|August 1, 1995
Central angiotensin II AT1-receptor antagonism in normal and heart-failed sheepM T Rademaker, M A Fitzpatrick, C J Charles, et al.Hypertension (Dallas, Tex. : 1979)|October 6, 1997
The effects of pathophysiological increments in brain natriuretic peptide in left ventricular systolic dysfunctionJ G Lainchbury, A M Richards, M G Nicholls, et al.Circulation|February 17, 1999
Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure GroupA M Richards, R Doughty, M G Nicholls, et al.Journal of the American College of Cardiology|June 13, 2001
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure GroupA M Richards, R Doughty, M G Nicholls, et al.The Journal of Clinical Endocrinology and Metabolism|December 1, 1988
Atrial natriuretic hormone has biological effects in man at physiological plasma concentrationsA M Richards, D McDonald, M A Fitzpatrick, et al.Pageof 38